IRIS-Synergy Cohort in the IRIS-DES Registry
IRIS Synergy
Evaluation of Effectiveness and Safety of Synergy™ Stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study
1 other identifier
observational
3,000
1 country
28
Brief Summary
The purpose of this study is to evaluate the relative effectiveness and safety of Synergy stent compared to other drug eluting stents.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2016
Longer than P75 for all trials
28 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 22, 2016
CompletedFirst Posted
Study publicly available on registry
March 25, 2016
CompletedStudy Start
First participant enrolled
August 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 24, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2027
ExpectedDecember 18, 2023
December 1, 2023
6.6 years
March 22, 2016
December 15, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Composite event
The number of events with the first occurrence of a composite event(death, non-fatal myocardial infarction, target vessel revascularization)
1 year
Secondary Outcomes (10)
All death
5 years
Cardiac death
5 years
Myocardial infarction
5 years
Composite event of death or myocardial infarction
5 years
Composite event of cardiac death or myocardial infarction
5 years
- +5 more secondary outcomes
Study Arms (1)
Synergy stent
Eligibility Criteria
Patients with Synergy stent
You may qualify if:
- Age 19 and more
- Intervention with Synergy stent
- Agreed with written informed consent form
You may not qualify if:
- Intervention with Synergy stent and other drug eluting stent at the same time
- Life expectancy of 1year and under
- Cardiac shock
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jung-min Ahnlead
- CardioVascular Research Foundation, Koreacollaborator
Study Sites (28)
Soon Chun Hyang University Hospital Bucheon
Bucheon-si, South Korea
Haeundae paik hospital, inje university
Busan, South Korea
Inje university Pusan Paik hospital
Busan, South Korea
Kosin University Gospel Hospital
Busan, South Korea
Pusan National University Hospital
Busan, South Korea
Pusan National University Yangsan Hospital
Busan, South Korea
Soon Chun Hyang University Hospital
Cheonan, South Korea
Gangwon National Univ. Hospital
Chuncheon, South Korea
Hallym University Chuncheon Sacred Heart Hospital
Chuncheon, South Korea
Daegu Catholic University Medical Center
Daegu, South Korea
Keimyung University Dongsan Medical Center
Daegu, South Korea
Yeungnam University Medical Center
Daegu, South Korea
Chungnam National University Hospital
Daejeon, South Korea
The Catholic University of Korea, Daejeon ST. Mary's Hospital
Daejeon, South Korea
Gangneung Asan Hospital
Gangneung, South Korea
Chonnam National University Hospital
Gwangju, South Korea
Incheon St. Mary's Hospital, The Catholic University of Korea
Incheon, South Korea
Cheju Halla General Hopsital
Jeju City, South Korea
Kwangju Christian Hospital
Kwangju, South Korea
CHA Bundang Medical Center, CHA University
Seongnam, South Korea
Seoul university Bundang hospital
Seongnam, South Korea
Asan Medical Center
Seoul, South Korea
Eulji general hospital
Seoul, South Korea
Korea University Guro Hospital
Seoul, South Korea
Kyung-Hee University Hospital
Seoul, South Korea
The Catholic University of Korea Seoul St. Mary's Hospital
Seoul, South Korea
The Catholic University of Korea, St. Paul's hospital
Seoul, South Korea
Wonju Severance Christian Hospital
Wŏnju, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- assistant professor
Study Record Dates
First Submitted
March 22, 2016
First Posted
March 25, 2016
Study Start
August 1, 2016
Primary Completion
February 24, 2023
Study Completion (Estimated)
February 1, 2027
Last Updated
December 18, 2023
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share
This is not a publicly funded trial.